Press release
Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
Company to Host Conference Call on Tuesday, February 25, 2025 at 8:30 am ET LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a
About this update from Orthofix Medical Inc.
Company to Host Conference Call on Tuesday, February 25, 2025 at 8:30 am ET LEWISVILLE, Texas --(BUSINESS WIRE)-- Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S. , and (646) 968-2525 in all other locations, and referencing the event passcode 5184023. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com. Internet Posting of Information Orthofix routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.orthofix.com . The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix . About Orthofix Orthofix is a global medical technology company headquartered in Lewisville, Texas . By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system. To learn more, visit Orthofix.com and follow on LinkedIn . View source version on businesswire.com : https://www.businesswire.com/news/home/20250128865236/en/ Investor Relations Julie Dewey , IRC Chief Investor Relations & Communications Officer [email protected] 209.613.6945 Media Relations Denise Landry [email protected] 214.937.2529 Source: Orthofix Medical Inc.
View stock analysis, news, and events for Orthofix Medical Inc.